Atlas Trials

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

Clinical trial NCT01021813 · COMPLETED

Trial details

NCT number
NCT01021813
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Insomnia
Start date
2009-12-10
Primary completion
2011-05-17
Enrollment
781

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.